Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Shaw

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Psychology & Health|September 23, 2025
A participatory-action research exploration of parent and clinician experiences of type-1 diabetes diagnosisDanielle Shaw, John Connolly, Lucy Piggin
The American Journal of Forensic Medicine and Pathology|November 24, 2005
Suicide in children and adolescents: a 10-year retrospective reviewDanielle Shaw, John R Fernandes, Chitra Rao
Current Opinion in Oncology|August 15, 2013
Angiogenesis as a target for the treatment of ovarian cancerDanielle Shaw, Andrew Clamp, Gordon C Jayson
The American Journal of Surgical Pathology|March 16, 2006
Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysisKatherine M Ceballos, Danielle Shaw, Dean Daya
Journal of Surgical Education|August 11, 2020
Don't Shoot the Messenger: Surgical Programs Can Do More to Keep Applicants InformedAlison N Pletch, Frederica Jackson, Danielle Shaw, et al.
Future Oncology (London, England)|October 24, 2024
Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progressionJonathan Krell, Danielle Shaw, John McGrane, et al.
Clinical Colorectal Cancer|December 13, 2025
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN StudyRosie Maye Solomon, Robert D Morgan, Laura Horsley, et al.
BMC Cancer|April 2, 2021
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker studyReem D Mahmood, Danielle Shaw, Tine Descamps, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Nature Communications|November 9, 2018
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancerGordon C Jayson, Cong Zhou, Alison Backen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Psychology & Health|September 23, 2025
A participatory-action research exploration of parent and clinician experiences of type-1 diabetes diagnosisDanielle Shaw, John Connolly, Lucy Piggin
The American Journal of Forensic Medicine and Pathology|November 24, 2005
Suicide in children and adolescents: a 10-year retrospective reviewDanielle Shaw, John R Fernandes, Chitra Rao
Current Opinion in Oncology|August 15, 2013
Angiogenesis as a target for the treatment of ovarian cancerDanielle Shaw, Andrew Clamp, Gordon C Jayson
The American Journal of Surgical Pathology|March 16, 2006
Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysisKatherine M Ceballos, Danielle Shaw, Dean Daya
Journal of Surgical Education|August 11, 2020
Don't Shoot the Messenger: Surgical Programs Can Do More to Keep Applicants InformedAlison N Pletch, Frederica Jackson, Danielle Shaw, et al.
Future Oncology (London, England)|October 24, 2024
Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progressionJonathan Krell, Danielle Shaw, John McGrane, et al.
Clinical Colorectal Cancer|December 13, 2025
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN StudyRosie Maye Solomon, Robert D Morgan, Laura Horsley, et al.
BMC Cancer|April 2, 2021
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker studyReem D Mahmood, Danielle Shaw, Tine Descamps, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Nature Communications|November 9, 2018
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancerGordon C Jayson, Cong Zhou, Alison Backen, et al.
Pageof 1